Share Success: Letters From Readers
I: From Tony V.
at Testimonial Submit Form Sunday, February 28, 2016 at 08:08:37
Hi, my 12 year old dog Angel was diagnosed with arthritis of the spine and was walking slowly.
I read another testimonial about EZORB helping a cat so I contacted Elixir Industry -EZORB customer service, and inquired about the use of EZORB in animals. Yes, it works for dogs, cats, horses and possibly a few other animals too.
I put a teaspoon of EZORB into Angel's food every day and the results were nothing short of a miracle. Within one week I noticed a HUGE difference in her movement. You would never know she had arthritis. Even the bulging vertebrae on her spine shrunk significantly over time and she has no symptoms of arthritis.
If you are looking for an alternative to arthritis medication for your pet, I highly recommend that you try EZORB for a few months first.
II: From Jean W.
Received 1/8/16, regular mail
I started taking this wonderful calcium 3 years ago. I had a bone spur which gave me great pain and in 3 months it was totally gone. I also suffered calf pain which went away after about 1 month. I was using a calcium product from a chiropractor who said his was pharmaceutical grade, but didn't work. All I can state is that this has worked when other's have failed.
Unfortunately I also had fractured my tailbone in 2008 and it took that pain away. I will never stop using this great product and I tell all those who will listen to me, this is very effective.
I praise God for all the people EZorb Company that make this great product, it has helped me and I know it will benefit all those who are willing to give it a try.
III: From Priya
Received at Testimonial
Submit Form Wednesday, December 16, 2015 at 10:28:23
Hi, my name is Priya. Would strongly recommend to try this.
I had bone spur for more than 2 years. Have been limping around and couldn't manage to walk even short distance. After doing enough research I came across this site and tried
to use ezorb. Its been a month and Wonders it worked! My heal pain is reduced drastically. Will continue using the product. God sent gift!
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public.
Research News: Dietary Fat May Not Link To Weight Gain
A prespecified analysis of the PREDIMED study suggests that an increase in the proportion of calories consumed as fat in the context of a Mediterranean-style diet does not have an adverse effect on bodyweight.
"These results have practical implications, because the fear of weight gain from high-fat foods need no longer be an obstacle to adherence to a dietary pattern such as the Mediterranean diet, which is known to provide much clinical and metabolic benefit", say Ramon Estruch (University of Barcelona, Spain) and co-researchers.
The findings from the 5-year, randomized dietary intervention trial come at a time when dietary fat recommendations are a hotly contested issue, with, for example, the controversial reception of the UK National Obesity Forum's recent guidelines, which include the advice to eat more fat.
At study baseline, the 7447 participants, who all had Type 2 diabetes and at least three cardiovascular risk factors, consumed around 40% of their daily calories from fat -already higher than the current 35% average in the UK and the 30% recommended by the World Health Organization.
During the 5 years of the study, this proportion increased slightly to 41.8% and 42.2% in patients assigned to adopt a Mediterranean diet with supplementary olive oil (50 mL/day) and nuts (30 g/day), respectively, but declined slightly to 37.4% in those assigned to receive standard low-fat dietary advice.
But the somewhat higher fat consumption did not have an adverse effect on the participants' bodyweight or waist circumference, although these increased slightly in all three groups over the 5-year study.
Relative to the control diet group, the groups assigned to the Mediterranean diet plus olive oil and nuts, respectively, had bodyweight decreases of 0.433 and 0.075 kg, with the former being statistically significant. This was independent of variables including baseline body mass index, total energy intake and leisure-time physical activity.
Likewise, participants' average waist circumference reduced by 0.549 and 0.936 cm in the olive oil and nuts groups, respectively, versus the control group, with both of these changes significant after accounting for baseline variables.
"Overall, our results show that an increase in vegetable fat intake from natural sources in the setting of a Mediterranean diet had little effect on bodyweight or central adiposity in older individuals who were mostly overweight or obese at baseline", say the researchers.
Their current analysis, reported in The Lancet Diabetes & Endocrinology, is a prespecified secondary analysis of PREDIMED. The previously reported primary analysis showed that adherence to the Mediterranean diet had cardiovascular benefits for patients with Type 2 diabetes. The patients were aged around 67 years, on average, and almost all were overweight or obese.
Original research was published in 2016 The Lancet Diabetes & Endocrinology.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.